These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34462794)

  • 1. Restrictions on the use of placebo in new COVID-19 vaccine trials.
    Bonati M
    Eur J Clin Pharmacol; 2022 Jan; 78(1):147-148. PubMed ID: 34462794
    [No Abstract]   [Full Text] [Related]  

  • 2. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 3. Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group.
    Singh JA; Kochhar S; Wolff J;
    Nat Med; 2021 Apr; 27(4):569-570. PubMed ID: 33727699
    [No Abstract]   [Full Text] [Related]  

  • 4. New placebo-controlled Covid-19 vaccine trials are ethically questionable; it's now about comparative effectiveness and availability of registered vaccines.
    Knottnerus JA
    J Clin Epidemiol; 2021 May; 133():175-176. PubMed ID: 33741502
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 vaccination and phase 1 cancer clinical trials.
    Yap TA; Siu LL; Calvo E; Lolkema MP; LoRusso PM; Soria JC; Plummer R; de Bono JS; Tabernero J; Banerji U
    Lancet Oncol; 2021 Mar; 22(3):298-301. PubMed ID: 33571468
    [No Abstract]   [Full Text] [Related]  

  • 6. Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants.
    Su S; Shao Y; Jiang S
    Emerg Microbes Infect; 2021 Dec; 10(1):439-441. PubMed ID: 33635184
    [No Abstract]   [Full Text] [Related]  

  • 7. A promising inactivated whole-virion SARS-CoV-2 vaccine.
    Isakova-Sivak I; Rudenko L
    Lancet Infect Dis; 2021 Jan; 21(1):2-3. PubMed ID: 33069282
    [No Abstract]   [Full Text] [Related]  

  • 8. Problematic Covid-19 vaccine trials in times of vaccine nationalism.
    Ravinetto R
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine trials ramp up in children and adolescents.
    Couzin-Frankel J
    Science; 2021 Feb; 371(6532):874-875. PubMed ID: 33632828
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine hesitancy in the COVID-19 era.
    Adhikari B; Cheah PY
    Lancet Infect Dis; 2021 Aug; 21(8):1086. PubMed ID: 34217431
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19: release approved vaccines for trials of new ones.
    Saville M
    Nature; 2021 Sep; 597(7875):178. PubMed ID: 34493842
    [No Abstract]   [Full Text] [Related]  

  • 12. Search for better COVID vaccines confounded by existing rollouts.
    Dolgin E
    Nature; 2021 Jan; 589(7842):340-341. PubMed ID: 33420405
    [No Abstract]   [Full Text] [Related]  

  • 13. Why Oxford's positive COVID vaccine results are puzzling scientists.
    Callaway E
    Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
    [No Abstract]   [Full Text] [Related]  

  • 14. "No" to placebo-controlled trials of Covid-19 vaccines.
    Ahmad A; Dhrolia MF
    Indian J Med Ethics; 2021; VI(2):1-7. PubMed ID: 33908356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question.
    Marjot T; Webb GJ; Barritt AS; Ginès P; Lohse AW; Moon AM; Pose E; Trivedi P; Barnes E
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):156-158. PubMed ID: 33444545
    [No Abstract]   [Full Text] [Related]  

  • 17. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
    Behr MA; Divangahi M; Schurr E
    J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
    Nemet I; Kliker L; Lustig Y; Zuckerman N; Erster O; Cohen C; Kreiss Y; Alroy-Preis S; Regev-Yochay G; Mendelson E; Mandelboim M
    N Engl J Med; 2022 Feb; 386(5):492-494. PubMed ID: 34965337
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Connors M; Graham BS; Lane HC; Fauci AS
    Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.